Tax Policy Update
Treasury & IRS Announce 280E Relief Is Coming: What Cannabis Operators Need to Know Right Now
On April 23, 2026, the U.S. Department of the Treasury and the IRS issued a landmark press release confirming that federal tax guidance is on the way — and that cannabis rescheduling is expected to have "significant positive tax consequences" for businesses in the medical marijuana industry. Here is exactly what was said, what it means, and what you should be doing today.
✓ Source verified: U.S. Treasury & IRS, April 23, 2026 · Corroborated by DOJ Final Order, Foley Hoag, Duane Morris, Canna Law Blog
What the Treasury and IRS actually said
The April 23rd press release is concise but carries enormous weight. Treasury and the IRS acknowledged the DOJ's Final Order — which took effect April 22, 2026 and was formally published in the Federal Register on April 28, 2026 — and announced they will issue formal guidance to address the principal federal tax consequences of rescheduling.
Rescheduling generally removes section 280E as a bar to claiming deductions and credits for businesses that as a result of the Final Order no longer traffic in Schedule I or II controlled substances under the CSA.
— U.S. Department of the Treasury & Internal Revenue Service, April 23, 2026
That sentence — coming directly from Treasury and the IRS — is the most consequential statement in cannabis tax history. For the first time, the federal government's tax authority has formally acknowledged that 280E no longer applies to qualifying cannabis businesses. But the details of who qualifies, when relief begins, and how to claim it are still being worked out.
Confirmed by multiple sources
The Treasury press release has been independently analyzed and corroborated by Foley Hoag LLP, Duane Morris LLP, the Canna Law Blog (Harris Sliwoski), Marijuana Moment, and The Marijuana Herald — all reaching consistent conclusions on the scope and timing of 280E relief.
Medical vs. recreational — who actually gets relief?
This is the most critical question for operators right now. The answer is nuanced and depends on your license type, your state, and how your operations are structured.
Gets 280E relief now
✓
State-licensed medical operators
Operators holding a state-issued medical marijuana license are explicitly covered by the DOJ Final Order and are no longer subject to 280E on those activities.
✓
FDA-approved cannabis products
Products in FDA-approved drug formulations (e.g. Epidiolex) are rescheduled and 280E-exempt on those sales.
✓
Pure-play medical states
States like Florida, Oklahoma, and Pennsylvania that only allow medical programs appear straightforward — all licensed activity is now Schedule III and 280E-exempt.
✓
Certain marijuana extracts & natural delta-9 THC
Certain naturally derived delta-9-THC compounds incorporated into licensed products are also covered by the Final Order.
Does NOT get relief yet
✗
Adult-use / recreational marijuana
Recreational cannabis sold without a state medical marijuana license remains Schedule I. 280E continues to apply to those sales until the broader rescheduling is finalized.
✗
Unlicensed cultivators & bulk marijuana
Marijuana crops and bulk marijuana not covered by a state medical license or FDA-approved product remain Schedule I.
✗
Synthetically derived THC
Synthetic cannabinoids and synthetically derived THC are explicitly excluded from the Final Order and remain Schedule I.
✗
Hemp-derived THC products
Hemp is separately regulated and is not affected by this rescheduling order.
The dual-license complexity
If your operation holds both a medical and adult-use license — as is common in states like California, Colorado, Michigan, and Illinois — you will need to apportion your expenses between medical (280E-exempt) and recreational (still 280E-subject) activities. Treasury has specifically flagged that forthcoming IRS guidance will address expense apportionment for multi-activity businesses. This is not a minor bookkeeping issue. It requires careful cost segregation analysis starting now.
How 280e relief changes tax return filing for operators
Below is a comprehensive breakdown of every meaningful way the Treasury and IRS announcement — combined with the DOJ Final Order — changes the tax filing landscape for qualifying cannabis businesses.
New tax benefits available to qualifying operators
1
Section 280E deductions now available
For the first time, state-licensed medical cannabis operators can deduct ordinary and necessary business expenses — rent, payroll, marketing, professional fees, utilities, depreciation, and more. Operators currently paying effective federal tax rates of 50–80% will see those rates normalize to standard corporate or pass-through rates.
2
Business tax credits now accessible
280E not only blocked deductions — it blocked business tax credits entirely. Rescheduling opens access to the R&D tax credit, energy credits, and other general business credits that have been off-limits. Many operators have never been able to utilize credits they technically qualified for.
3
Transition rule: relief applies to the full 2026 tax year
Treasury confirmed that 280E relief will generally apply to the entire taxable year that includes the effective date of the Final Order (April 28, 2026). For calendar-year businesses, that means the full 2026 tax year — not just the portion after April 28. Your 2026 Form 1120 or Schedule K-1 will be filed under normal tax rules for qualifying medical activities.
4
Potential retroactive relief under consideration
Acting AG Todd Blanche's Final Order explicitly encouraged Treasury to consider "retrospective relief" from 280E liability for prior taxable years in which operators held a state medical marijuana license. While Treasury has not committed to this yet, the door is open. Operators should preserve amended return options (generally 3 years back) and consider filing protective claims.
5
COGS-only method becomes less critical
Under 280E, operators have been forced into creative cost-of-goods-sold allocation strategies to maximize deductions by embedding non-COGS expenses into inventory costs. With 280E lifted for qualifying activities, this approach is still valid for adult-use portions but becomes less urgent for medical operations — and potentially riskier if it was done aggressively.
6
Expense apportionment between medical and recreational activities
IRS guidance is expected to clarify how shared expenses — labor, facilities, management overhead — must be allocated between 280E-exempt medical activity and still-subject recreational activity. This will likely require a methodology election and consistent application going forward. Operators should begin documenting allocation methodologies today.
7
Entity structure review is now urgent
Many cannabis businesses elected C-Corp status specifically to reduce 280E exposure through lower gross income. With ordinary deductions now available, the double-taxation structure of a C-Corp may no longer be optimal for all operators. Pass-through entities (partnerships, S-Corps) may become more tax-efficient depending on owner income levels. Review your structure now — before filing 2026 returns.
8
State tax exposure does not automatically change
Federal 280E relief does not override state-level tax rules. Some states have conformed to 280E in their own tax codes — and those disallowances remain in force. California, for instance, has historically not conformed to IRC changes automatically. Operators must analyze both federal and state tax positions separately for each jurisdiction they operate in.
9
DEA registration triggers its own tax considerations
The DEA Medical Marijuana Dispensary Registration Portal opened April 29, 2026. Operators who register within 60 days of the Federal Register publication date (by approximately June 27, 2026) qualify for the expedited review process. DEA registration strengthens your position as a "state licensee" for both 280E relief purposes and any potential retroactive relief the IRS may provide.
10
OBBA-related amended returns may also apply
The Omnibus Business and Banking Act (OBBA), signed into law in July 2025, created certain elections that the IRS will allow to be made on amended returns going back to 2022. Cannabis operators should evaluate whether OBBA elections interact favorably with the new 280E relief on prior year filings.
What about recreational operators — is there a path to relief?
Yes — but it requires a separate rulemaking process that is just getting started.
The DOJ's Final Order was explicitly limited to state-licensed medical marijuana. However, the same order simultaneously announced that DEA would commence an expedited administrative hearing on June 29, 2026 to evaluate broader rescheduling of all cannabis — including adult-use recreational markets.
If that broader rescheduling is completed, it would extend Schedule III status to recreational cannabis and eliminate 280E for those operators as well. But this process has its own timeline, its own risk of legal challenges, and no guaranteed outcome.
The DEA's ALJ problem
The prior rescheduling hearing process stalled because Chief Administrative Law Judge John Mulrooney retired in August 2025, leaving the DEA with no ALJ to hear any matter. How the June 29, 2026 hearing proceeds without an ALJ in place is one of the key unresolved questions legal experts are watching closely.
For operators in adult-use only states, or those with blended medical/recreational programs, the current picture is:
Recreational operators: current status
!
280E still applies to adult-use sales
Until the broader rescheduling is finalized, recreational cannabis sales are still Schedule I and 280E deduction disallowance remains in full effect for those activities.
!
Medical portion of blended operations may qualify now
If you hold a state medical marijuana license alongside an adult-use license, the medical portion of your operations may already be 280E-exempt — even today. This requires careful expense segregation between the two streams.
!
Broader relief: best case late 2026, realistic 2027
If the June 29 hearing proceeds efficiently and DOJ moves quickly, a final rule covering all cannabis could arrive in late 2026. Litigation risk and procedural complexity make 2027 a more realistic planning baseline for full 280E elimination.
!
Congress could also act
Congress could pass legislation to extend 280E relief to all cannabis, or conversely, codify 280E into the tax code to prevent relief even after rescheduling. Both scenarios are being tracked by industry advocates. The SAFER Banking Act also remains in play as a separate legislative track.
Key dates and deadlines you cannot miss
-
Effective
April 22, 2026 — DOJ Final Order takes effect
State-licensed medical marijuana moves to Schedule III. 280E no longer applies to qualifying medical activities from this date forward.
-
Published
April 28, 2026 — Federal Register publication date
Official effective date of the Final Order. This date starts all 60-day and 30-day deadline clocks. For most calendar-year businesses, the entire 2026 tax year is the first 280E-exempt year for medical activities.
-
Act now
By ~June 27, 2026 — DEA expedited registration deadline
Medical marijuana operators who register with the DEA within 60 days of Federal Register publication qualify for expedited review and can continue operating under state licenses during the review process. Portal opened April 29, 2026. Annual fee: $794.
-
Upcoming
June 29, 2026 — Broader rescheduling hearing begins
DEA administrative hearing to evaluate full Schedule I → Schedule III rescheduling of all cannabis, including adult-use. Adult-use operators should monitor this closely and consider whether to participate directly or through industry associations.
-
Pending
TBD — IRS and Treasury formal guidance published
Treasury announced guidance is forthcoming but gave no specific timeline. Expect a Notice or Revenue Procedure addressing: the transition rule, expense apportionment methodology, amended return procedures, and potential retroactive relief rules.
-
Future
2026 tax year filings (due April 2027)
For calendar-year businesses, your 2026 federal return will be the first return filed under the new rules for qualifying medical activities. This is also likely the filing where amended return strategies for prior years must be implemented or protected.
What operators should be doing right now
Immediate action items
1
Confirm your license classification
Determine whether your state license qualifies as a "state medical marijuana license" under the new definition at 21 CFR § 1300.01. If you hold a blended or dual license, document the medical versus recreational split in your operations.
2
Register with the DEA before June 27, 2026
The expedited registration window closes approximately June 27, 2026. Filing within 60 days allows you to continue operating under your state license during the review process and strengthens your position for tax relief. Fee: $794 via the DEA portal.
3
Begin cost segregation and expense apportionment immediately
If you operate in both medical and adult-use markets, you need a defensible, documented methodology for allocating shared expenses. This work should begin now — not when IRS guidance drops — so you have 2026 records to support your position.
4
Preserve your right to file amended returns
Do not let prior year amended return windows close. Generally you have 3 years from the original filing date. If retroactive relief is granted, you want to be positioned to file. Consider filing protective refund claims now while the guidance is pending.
5
Review your entity structure
The tax calculus that drove your original entity election has changed materially. A cannabis CPA and tax attorney should model your post-280E tax burden under your current structure versus alternatives before the end of 2026.
6
Do not assume state tax relief — confirm it
Check your state's conformity to the IRC. Some states have decoupled from federal 280E treatment. Others have their own excise taxes that remain in place regardless of federal rescheduling. Your effective state tax burden requires a separate analysis.
Wait for formal IRS guidance before amending returns
While the direction is clear, Treasury and the IRS have not yet published the formal rules. Filing aggressive amended returns before guidance is issued could expose you to penalties or audit risk. Consult with a cannabis-specialized CPA and tax attorney before taking any retroactive filing position. The guidance is expected — the timing is not yet confirmed.
MindfulCPAs specializes exclusively in cannabis tax strategy, 280E planning, cost segregation, and post-rescheduling advisory services. If you are a cannabis operator, cultivator, or multi-state operator navigating the transition to a post-280E world, the decisions you make in the next 60 days will have a material impact on your 2026 and prior-year tax positions. Reach out to start a planning conversation.
